PARK Park Dental Partners, Inc. - Common Stock
PARK Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
PARK Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
PARK Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 2 25.0%
- Buy 5 62.5%
- Hold 1 12.5%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
2 analysts · 2026-08-16Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $0.66 | $0.34 | 0.32% |
| March 31, 2026 | $0.44 | $0.20 | 0.24% |
| Dec. 31, 2025 | $0.30 | $-0.06 | 0.36% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PARK | — | — | — | — | — | — |
| AIRS | $128M | -10.4 | -15.8% | -7.7% | -13.1% | — |
| NAKA | $154M | -1.4 | -33.0% | -2867.7% | -20.0% | — |
| PIII | — | — | — | — | — | — |
| DCGO | $87M | -0.5 | -47.7% | -56.6% | -78.5% | — |
| PRPO | $41M | -99.9 | 29.8% | -1.5% | -2.7% | 44.5% |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet 19
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $25M | |
| Receivables | $7M | |
| Inventory | $930.0K | |
| Prepaid Expense | $2M | |
| Current Assets | $38M | |
| Goodwill | $17M | |
| Intangibles | $11M | |
| Total Assets | $178M | |
| Current Liabilities | $36M | |
| Capital Leases | $42M | |
| Other Non-current Liabilities | $486.0K | |
| Total Liabilities | $156M | |
| Long-term Debt | $12M | |
| Common Stock | $1.0K | |
| Retained Earnings | $-6M | |
| Treasury Stock | $737.0K | |
| Stockholders' Equity | $22M | |
| Liabilities + Equity | $178M | |
| Shares Outstanding | 4,247,018 |
Income Statement 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Revenue | $66M | $63M | $63M | $59M | |
| Cost of Revenue | $57M | $56M | $51M | $49M | |
| Gross Profit | $10M | $6M | $12M | $10M | |
| SG&A Expense | $8M | $8M | $7M | $7M | |
| Operating Income | $1M | $-2M | $4M | $3M | |
| Pretax Income | $1M | $-2M | $4M | $2M | |
| Income Tax | $-230.0K | $-2M | $1M | $646.0K | |
| Net Income | $1M | $-390.0K | $3M | $2M | |
| EPS (Basic) | $0.30 | $-0.09 | $1.45 | $0.88 | |
| EPS (Diluted) | $0.22 | $-0.09 | $1.45 | $0.88 | |
| Shares (Basic) | 4,571,346 | 4,383,073 | 1,772,662 | 1,783,352 | |
| Shares (Diluted) | 6,235,305 | 4,383,073 | 1,772,662 | 1,783,352 | |
| EBITDA | $1M | $503.0K | · | · |
Balance Sheet 20
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $24M | $24M | · | · | |
| Receivables | $8M | $7M | · | · | |
| Inventory | $959.0K | $949.0K | · | · | |
| Prepaid Expense | $4M | $3M | · | · | |
| Current Assets | $40M | $38M | · | · | |
| Goodwill | $17M | $17M | · | · | |
| Intangibles | $13M | $12M | · | · | |
| Total Assets | $186M | $180M | · | · | |
| Current Liabilities | $35M | $35M | · | · | |
| Capital Leases | $42M | $41M | · | · | |
| Other Non-current Liabilities | $659.0K | $537.0K | · | · | |
| Total Liabilities | $156M | $154M | · | · | |
| Long-term Debt | $11M | $12M | · | · | |
| Total Debt | $11M | $12M | · | · | |
| Common Stock | $1.0K | $1.0K | · | · | |
| Retained Earnings | $-5M | $-6M | · | · | |
| Treasury Stock | $737.0K | $737.0K | · | · | |
| Stockholders' Equity | $30M | $25M | · | · | |
| Liabilities + Equity | $186M | $180M | · | · | |
| Shares Outstanding | 4,704,780 | 4,515,054 | · | · |
Cash Flow 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $3M | $4M | · | · | |
| Deferred Tax | $-497.0K | $-470.0K | · | · | |
| Other Non-cash | · | $-521.0K | · | · | |
| Operating Cash Flow | $5M | $5M | $3M | $6M | |
| CapEx | $2M | $2M | $2M | $2M | |
| Investing Cash Flow | $-3M | $-5M | $-3M | $-3M | |
| Net Debt Issued | · | $-473.0K | · | · | |
| Financing Cash Flow | $-1M | $-1M | $-1M | $-2M | |
| Free Cash Flow | · | $3M | · | · |
Profitability 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Gross Margin | 14.4% | 10.2% | · | · | |
| Operating Margin | 1.9% | -3.0% | · | · | |
| Net Margin | 2.0% | -0.62% | · | · | |
| Pretax Margin | 1.7% | -3.2% | · | · | |
| EBITDA Margin | 1.9% | 0.80% | · | · | |
| ROA | 1.5% | -0.43% | · | · | |
| ROE | 9.0% | -3.1% | · | · | |
| ROIC | 3.7% | -0.99% | · | · |
Liquidity & Solvency 4
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | · | |
| Quick Ratio | 0.9 | 0.9 | · | · | |
| Debt / Equity | 0.4 | 0.5 | · | · | |
| LT Debt / Equity | 0.3 | 0.4 | · | · |
Efficiency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | · | · | |
| Inventory Turnover | 118.2 | 118.7 | · | · | |
| Receivables Turnover | 16.7 | 18.4 | · | · |
Valuation (TTM) 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Market Cap | $101M | $76M | · | · | |
| Enterprise Value | $88M | $63M | · | · | |
| P/B | 3.4 | 3.0 | · | · | |
| P / Cash Flow | · | 15.1 | · | · | |
| P / FCF | · | 27.8 | · | · | |
| EV / EBITDA | 70.1 | 125.0 | · | · | |
| EV / FCF | · | 23.1 | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 24 filers · $22.2M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 9 (+2 vs prior Q) | 3 (+3 vs prior Q) | 7 (+3 vs prior Q) | 4 (0 vs prior Q) | +292K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| KENNEDY CAPITAL MANAGEMENT LLC | $5,103,148 | 236,805 | 23.00% | Shares |
| HEARTLAND ADVISORS INC | $4,310,000 | 200,000 | 19.43% | Shares |
| Pacific Ridge Capital Partners, LLC | $3,722,719 | 172,748 | 16.78% | Shares |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | $1,444,281 | 67,020 | 6.51% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,431,265 | 66,416 | 6.45% | Shares |
| CITADEL ADVISORS LLC | $1,151,826 | 53,449 | 5.19% | Shares |
| ACCESS FINANCIAL SERVICES, INC. | $1,070,755 | 49,687 | 4.83% | Shares |
| Russell Investments Group, Ltd. | $975,324 | 45,258 | 4.40% | Shares |
| ROYAL BANK OF CANADA | $958,000 | 44,464 | 4.32% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $400,830 | 18,600 | 1.81% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $365,358 | 16,954 | 1.65% | Shares |
| SEI INVESTMENTS CO | $346,028 | 16,057 | 1.56% | Shares |
| Boston Partners | $285,390 | 13,243 | 1.29% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $260,389 | 12,083 | 1.17% | Shares |
| Quadrature Capital Ltd | $221,340 | 10,271 | 1.00% | Shares |
| MARSHALL WACE, LLP | $96,285 | 4,468 | 0.43% | Shares |
| MORGAN STANLEY | $10,775 | 500 | 0.05% | Shares |
| JPMORGAN CHASE & CO | $10,523 | 500 | 0.05% | Shares |
| BlackRock, Inc. | $7,823 | 363 | 0.04% | Shares |
| Tower Research Capital LLC (TRC) | $4,633 | 215 | 0.02% | Shares |
| CITIGROUP INC | $4,245 | 197 | 0.02% | Shares |
| OSAIC HOLDINGS, INC. | $2,155 | 100 | 0.01% | Shares |
| BARCLAYS PLC | $1,767 | 82 | 0.01% | Shares |
| Smartleaf Asset Management LLC | $1,221 | 58 | 0.01% | Shares |
Company insiders 7 insiders · 4 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Peter G Swenson | CEO and Chairman | June 15, 2026 A | — | 0 | 0 | $0 |
| Christopher James Bernander | Chief Financial Officer | June 15, 2026 A | — | 0 | 0 | $0 |
| Christopher Eugene Steele | Chief Clinical Officer - General Practices | June 15, 2026 A | — | 0 | 0 | $0 |
| Alan Siems Law | Chief Clinical Officer - Specialty Practices | June 15, 2026 A | — | 0 | 0 | $0 |
| Christopher Charles Smith | Director | June 15, 2026 A | — | 0 | 0 | $0 |
| Anna Marie Schaefer | Director | June 15, 2026 A | — | 0 | 0 | $0 |
| Philip Irving Smith | Director | June 15, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.